Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Sensus Healthcare, Inc. (SRTS)
|
Add to portfolio |
|
|
|
| Price: |
$6.83
| | Metrics |
| OS: |
16.4
|
M
| |
|
|
| Market cap: |
$112
|
M
| |
|
|
|
Net cash:
|
$20.1
|
M
| |
$1.22
|
per share
|
|
EV:
|
$91.9
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 27.0 | 9.6 | 27.3 | 26.4 | 20.6 | 14.8 | 10.3 |
| Revenue growth | -100.0% | 182.4% | -64.9% | 3.2% | 28.4% | 39.0% | 44.2% | 76.8% |
| Cost of goods sold | 0.0 | 10.1 | 4.3 | 9.7 | 9.5 | 6.8 | 5.0 | 3.7 |
| Gross profit | 0.0 | 17.0 | 5.2 | 17.6 | 16.9 | 13.8 | 9.8 | 6.6 |
| Gross margin | | 62.8% | 54.8% | 64.4% | 64.0% | 67.0% | 66.5% | 64.1% |
| Selling, general and administrative | 0.0 | | | | | | | |
| Sales and marketing | 0.0 | 5.3 | 5.3 | 9.1 | 8.5 | 8.3 | 4.9 | 3.7 |
| Research and development | | 3.4 | 4.2 | 6.4 | 6.3 | 5.5 | 1.8 | 1.5 |
| General and administrative | 0.0 | 4.7 | 4.0 | 4.0 | 4.1 | 3.7 | 3.5 | 1.6 |
| EBITA | 0.0 | 4.1 | -8.1 | -1.9 | -1.9 | -3.6 | -0.3 | -0.1 |
| EBITA margin | | 15.2% | -84.8% | -6.9% | -7.2% | -17.6% | -1.8% | -1.2% |
| Amortization of intangibles | | | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| EBIT | 0.0 | 4.1 | -8.2 | -2.0 | -2.0 | -3.7 | -0.4 | -0.2 |
| EBIT margin | | 15.2% | -86.0% | -7.2% | -7.6% | -18.1% | -2.5% | -2.2% |
| Pre-tax income | 24.2 | 4.1 | -6.8 | -1.7 | -2.0 | -3.7 | -0.3 | -0.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 24.2 | 4.1 | -6.8 | -1.7 | -2.0 | -3.7 | -0.3 | -0.8 |
| Net margin | | 15.2% | -71.4% | -6.2% | -7.7% | -18.0% | -2.3% | -7.3% |
| |
| Diluted EPS | $1.47 | $0.25 | ($0.42) | ($0.10) | ($0.14) | ($0.28) | ($0.03) | ($0.08) |
| Shares outstanding (diluted) | 16.5 | 16.5 | 16.4 | 16.2 | 14.1 | 13.2 | 12.0 | 9.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|